NGTS -EB-7, an eccentric, long-period, low-mass eclipsing binary
Monthly Notices of the Royal Astronomical Society · 15.01.2025 · 537 (1) · 35-55
DOI: 10.1093/mnras/stae2799 ↗Kurz gefasst
Fachartikel in der Zeitschrift Monthly Notices of the Royal Astronomical Society, online erschienen am 20.12.2024. Verfasst von Toby Rodel und 37 weiteren Autor:innen. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 122 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NASA, STFC, FONDECYT.
Abstract (Originalsprache)
Despite being the most common types of stars in the Galaxy, the physical properties of late M dwarfs are often poorly constrained. A trend of radius inflation compared to evolutionary models has been observed for earlier type M dwarfs in eclipsing binaries, possibly caused by magnetic activity. It is currently unclear whether this trend also extends to later type M dwarfs below the convective boundary. This makes the discovery of lower mass, fully convective, M dwarfs in eclipsing binaries valuable for testing evolutionary models – especially in longer-period binaries where tidal interaction between the primary and secondary is negligible. With this context, we present the discovery of the NGTS-EB-7 AB system, an eclipsing binary containing a late M dwarf secondary and an evolved G-type primary star. The secondary star has a radius of $0.125\pm 0.006$ R$_{\odot }$, a mass of $0.096^{+0.003}_{-0.004}$ M$_{\odot }$ and follows a highly eccentric (e = $0.71436\pm 0.00085$) orbit every $193.35875\pm 0.00034$ d. This makes NGTS-EB-7 AB the third longest-period eclipsing binary system with a secondary smaller than 200 ${\rm M}_{\rm J}$ with the mass and radius constrained to better than 5 per cent. In addition, NGTS-EB-7 is situated near the centre of the proposed LOPS2 southern field of the upcoming PLATO mission, allowing for detection of the secondary eclipse and measurement of the companion’s temperature. With its long-period and well-constrained physical properties – NGTS-EB-7 B will make a valuable addition to the sample of M dwarfs in eclipsing binaries and help in determining accurate empirical mass/radius relations for later M dwarf stars.
Förderung
- NASA
- STFC
- FONDECYT
- Swiss National Science Foundation
Zitieren
APA
Rodel, T., Watson, C. A., Ulmer-Moll, S., Gill, S., Maxted, P. F. L., Casewell, S. L., Brahm, R., Wilson, T. G., Costes, J. C., Eschen, Y. N. E., Doyle, L., Freckelton, A. V., Alves, D. R., Apergis, I., Bayliss, D., Bouchy, F., Burleigh, M. R., Dumusque, X., Eberhardt, J., …, & Wheatley, P. J. (2025). NGTS -EB-7, an eccentric, long-period, low-mass eclipsing binary. Monthly Notices of the Royal Astronomical Society, 537(1), 35-55. https://doi.org/10.1093/mnras/stae2799
Vancouver
Rodel T, Watson CA, Ulmer-Moll S, Gill S, Maxted PFL, Casewell SL, et al. NGTS -EB-7, an eccentric, long-period, low-mass eclipsing binary. Monthly Notices of the Royal Astronomical Society. 2025;537(1):35-55. doi:10.1093/mnras/stae2799
BibTeX
@article{Rodel2025,
author = {Rodel, Toby and Watson, Christopher A and Ulmer-Moll, Solène and Gill, Samuel and Maxted, Pierre F L and Casewell, Sarah L and Brahm, Rafael and Wilson, Thomas G and Costes, Jean C and Eschen, Yoshi Nike Emilia and Doyle, Lauren and Freckelton, Alix V and Alves, Douglas R and Apergis, Ioannis and Bayliss, Daniel and Bouchy, Francois and Burleigh, Matthew R and Dumusque, Xavier and Eberhardt, Jan and Fernández, Jorge Fernández and Gillen, Edward and Goad, Michael R and Hawthorn, Faith and Helled, Ravit and Henning, Thomas and Hobbs, Katlyn L and Jenkins, James S and Jordán, Andrés and Kendall, Alicia and Lendl, Monika and McCormac, James and Mooij, Ernst J W de and O’Brien, Sean M and Saha, Suman and Pinto, Marcelo Tala and Trifonov, Trifon and Udry, Stéphane and Wheatley, Peter J},
title = {NGTS -EB-7, an eccentric, long-period, low-mass eclipsing binary},
journal = {Monthly Notices of the Royal Astronomical Society},
year = {2025},
volume = {537},
number = {1},
pages = {35--55},
doi = {10.1093/mnras/stae2799}
}
EUVIMED